Genya Dana is the Head of Precision Medicine at the World Economic Forum. She leads the co-design, testing and scaling of pilot projects with governments, industry, civil society, and academia to tackle policy and governance challenges around moving toward a tailored and personalized approach to health and healthcare. She is an internationally recognized expert on the policy and science of synthetic biology and gene editing, and has advised foreign policy makers on the implications of emerging technologies.
She served as a U.S. negotiator on science, technology and innovation in multi-lateral organizations like the United Nations, worked to advance science, technology and innovation for sustainable development with a focus on Africa, and developed international partnerships to support scientific research on brain science and biological engineering.
She has a biology degree from Emory University, an MSc in science, technology and environmental policy and a PhD in risk assessment from the University of Minnesota, and conducted her PhD research in South Africa.